Industry Reports
Sanofi delivers solid 2012 results despite patent expirations
In the fourth quarter of 2012, Sanofi generated sales of €8,526 million, an increase of 0.2% on a reported basis. Exchange rate movements had...
Industry Reports
Roche delivers strong 2012 results
Roche delivered a strong performance in 2012, with Group sales rising 4% to 45.5 billion Swiss francs due to growing demand for its cancer...
Industry Reports
AstraZeneca fourth quarter and full year results 2012
AstraZeneca's revenue in the fourth quarter was down 15 percent at constant exchange rates (CER) and declined by 16 percent on an actual basis...
Industry Reports
Bristol-Myers Squibb reports fourth quarter financial results
Bristol-Myers Squibb Company has announced results for the fourth quarter of 2012 highlighted by regulatory approvals for Eliquis and Forxiga. ...
Industry Reports
Pivotal Therapeutics reports third quarter 2012 financial results
Pivotal Therapeutics Inc. , a specialty pharmaceutical company with a focus on cardiovascular disease and overall health today announced its financial results and operational...
Industry Reports
Hybrigenics 2012 first-half results
Plus 5 per cent growth of Hybrigenics’ operating revenues An exceptional revenue of EUR 0.96 million EUR 3.3 million raised...
Industry Reports
Johnson & Johnson Reports 2012 Third-Quarter Results
Sales of $17.1 Billion increased 6.5% Versus 2011 Third Quarter; Third-Quarter EPS was $1.05 Excluding Special Items, 2012 Third-Quarter EPS...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.